I spent years of my career applying ML to clinical trial operations and this is what drew me to #PLTR initially. Palantir #AIP delivers safer and more effective trials for patients, fantastic to see our work with Parexel publicized! fiercebiotech.com/cro/parexel-st…

Thrilled to finally share this work with everyone! #ai #LLM #ClinicalTrials #pltr $pltr

We generated $634 million in revenue in Q1 2024, a result that surpassed the upper end of our guidance by a significant amount. Over the same period, we earned $106 million in profit — the largest quarterly profit in our company’s twenty-year history. See our full results:

I am kicking off developer-oriented meetups across the US (l33t-ups?). What to emcee/host in your city? DM me. Explore Build with AIP . If your project rocks, we will fly you out to the next AIPCon to share your work with the world.

Coming soon... 🔮👀

Introducing Build with AIP, a curated library of reference examples, tutorials, and starter kits designed to turbocharge application building. We’re offering trial access to the first 100 users to sign up: signup.palantirfoundry.com/signup?signupP…

Move AI beyond chat and into production. AIPCon 4 is here. Tomorrow. Tune in to hear from AARP, Jacobs, @United, Fujitsu Global, Tampa General Hospital, Parexel, Cleveland Clinic, Cone Health, Swiss Re, Kinder Morgan, and more. Watch live: palantir.com/aipcon4

→ 6-7 hours saved per SME for each study design → Reduced time to data delivery by 50% Parexel takes the #AIPCon stage to showcase their Study Design Optimization Tool.

Live at AIPCon today Palantir . With Parexel Jonathan Shough, CIO and Dan Ballard, SVP. "We were looking for a partner that actually produces shit”. $PLTR #ClinicalTrials #ai #aipcon

I have yet to find a system we can't connect to. Now we just added another 150 out of the box connectors. Try it out, let me know what you think.

🎓 Thrilled to announce my graduation from the Luminal Interventional Endoscopy Fellowship at Mayo Clinic Arizona! Immensely grateful for the incredible mentorship of Dr. Norio Fukami, Terry Jue, Rahul Pannala, Michelle Anderson, and Douglas Faigel. A year-long experience of

Palantir generated $678m in revenue in Q2 2024, a $25m beat vs analyst estimates of $652 - $653m and an increase of 27% y/y. And we now expect to generate $697 - $701m in revenue in Q3 2024, outperforming analyst estimates of $679 - $681m by $16 - $22m.

Approximately one in four participants without an observable response to commands performed a cognitive task on fMRI or EEG! This has implications on the way we should treat/manage patients with consciousness disorders.

💪🏾

Proud founder to see Palantir added to S&P 500! Congrats to all: Alex, Peter, Stephen, Shyam Sankar & Aki et al, and 1000s more who contributed over the years. Not as important as bad guys eliminated, liberty preserved, billions $s saved or other impact, but a fun milestone!

$PLTR 😎

The FDE role is being lionized and replicated after being hated on for a long time. I wrote about the essence of the FDE and what the replicants are missing. Full essay on my blog. “One of Palantir’s secrets in the Zero to One sense of the word has been the FDE. We were